Scibetta James S

Insider Buys Quantity –
6
2019-08-21PurchaseAquestive Therapeutics, Inc.
AQST
1,800
0.0068%
$3.81$6,858+7.92%
2019-08-20PurchaseAquestive Therapeutics, Inc.
AQST
22,620
0.0909%
$3.80$86,001+15.08%
2019-08-19PurchaseAquestive Therapeutics, Inc.
AQST
21,522
0.0873%
$3.77$81,095+17.25%
2017-09-07PurchaseMatinas BioPharma Holdings, Inc.
MTNB
director
10,000
0.0102%
$1.29$12,900
2017-06-05SalePacira BioSciences, Inc.
PCRX
President
3,932
0.0096%
$43.32$170,338-16.72%
2017-05-15SalePacira BioSciences, Inc.
PCRX
President
40,000
0.0551%
$28.34$1.13M-26.76%
2017-01-17SalePacira BioSciences, Inc.
PCRX
President
40,000
0.1027%
$38.53$1.54M+10.19%
2016-11-15SalePacira BioSciences, Inc.
PCRX
President
40,000
0.0544%
$19.05$762,200+7.05%
2016-08-15SalePacira BioSciences, Inc.
PCRX
President
50,000
0.1338%
$45.21$2.26M-7.91%
2015-09-11PurchasePacira BioSciences, Inc.
PCRX
SVP, Chief Financial Officer
5,000
0.0133%
$61.37$306,850-19.77%
2015-02-06SalePacira BioSciences, Inc.
PCRX
SVP, Chief Financial Officer
30,000
0.0836%
$111.22$3.34M-39.16%
2014-11-07SalePacira BioSciences, Inc.
PCRX
SVP, Chief Financial Officer
30,000
0.0843%
$87.18$2.62M-8.44%
2014-08-08SalePacira BioSciences, Inc.
PCRX
SVP, Chief Financial Officer
30,000
0.0822%
$99.63$2.99M-8.73%
2014-05-08SalePacira BioSciences, Inc.
PCRX
SVP, Chief Financial Officer
30,000
0.084%
$75.05$2.25M+22.95%
2013-12-30SalePacira BioSciences, Inc.
PCRX
Chief Financial Officer
20,000
0.03%
$28.58$571,600+52.48%
2013-09-30SalePacira BioSciences, Inc.
PCRX
Chief Financial Officer
20,000
0.0298%
$24.18$483,500+49.34%
2013-06-28SalePacira BioSciences, Inc.
PCRX
Chief Financial Officer
20,000
0.0309%
$14.83$296,560+94.79%
2013-03-28SalePacira BioSciences, Inc.
PCRX
Chief Financial Officer
20,000
0.0319%
$15.05$301,000+64.43%
2011-02-15PurchasePacira BioSciences, Inc.
PCRX
Chief Financial Officer
10,000
0.1017%
$7.04$70,400+31.04%